Advanced search
Publication Cover
Journal of Plastic Surgery and Hand Surgery Volume 48, 2014 - Issue 1
Journal homepage
491
Views
17
CrossRef citations to date
0
Altmetric
Original Scientific Reports

Dermatofibrosarcoma protuberans: Clinical series, national Danish incidence data and suggested guidelines

Javed AkramDepartment of Plastic SurgeryCorrespondence[email protected]
,
Gitte WoolerDepartment of Pathology, Roskilde University Hospital, Health Care Region Zealand, Denmark
&
Jørgen Lock-AndersenDepartment of Plastic Surgery
Pages 67-73 | Accepted 04 Jun 2013, Published online: 09 Jul 2013

References

  • Bogucki B, Neuhaus I, Hurst EA. Dermatofibrosarcoma protuberans: a review of the literature. Dermatol Surg 2012;38:537–51.
  • Llombart B, Serra-Guillen C, Monteagudo C, et al. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol 2013;30:13–28.
  • Malhotra B, Schuetze SM. Dermatofibrosarcoma protruberans treatment with platelet-derived growth factor receptor inhibitor: a review of clinical trial results. Curr Opin Oncol 2012;24:419–24.
  • Hussain SK, Sundquist J, Hemminki K. Incidence trends of squamous cell and rare skin cancers in the Swedish national cancer registry point to calendar year and age-dependent increases. J Invest Dermatol 2010;130:1323–8.
  • Monnier D, Vidal C, Martin L, et al. Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol 2006;20:1237–42.
  • Weedon D. Weedon's skin pathology. 3rd ed. Churcill Livingstone Elsevier Ltd, London, United Kingdom: 2010. p 833–5.
  • Mckee PH, Brenn T, Calonje JE, et al. Pathology of the skin: with clinical correlations. 3rd ed. Elsevier Mosby, Philadelpia: 2010. p 1729–34.
  • Kuzel P, Metelitsa AI, Dover DC, et al. Epidemiology of dermatofibrosarcoma protuberans in Alberta, Canada, from 1988 to 2007. Dermatol Surg 2012;38:1461–8.
  • Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol 2007;56:968–73.
  • Miller SJ, Alam M, Andersen JS, et al. Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw 2012;10:312–18.
  • Lemm D, Mugge LO, Mentzel T, et al. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol 2009;135:653–65.
  • Fields RC, Hameed M, Qin LX, et al. Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Ann Surg Oncol 2011;18:328–36.
  • Bowne WB, Antonescu CR, Leung DH, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 2000;88:2711–20.
  • Johnson-Jahangir H, Ratner D. Advances in management of dermatofibrosarcoma protuberans. Dermatol Clin 2011;29:191–200, viii.
  • Llombart B, Monteagudo C, Sanmartin O, et al. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors. J Am Acad Dermatol 2011;65:564–75.
  • Cai H, Wang Y, Wu J, et al. Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China. J Surg Oncol 2012;105:142–8.
  • Farma JM, Ammori JB, Zager JS, et al. Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol 2010;17:2112–18.
  • Heuvel ST, Suurmeijer A, Pras E, et al. Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol 2010;36:89–94.
  • Paradisi A, Abeni D, Rusciani A, et al. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev 2008;34:728–36.
  • Popov P, Bohling T, Asko-Seljavaara S, et al. Microscopic margins and results of surgery for dermatofibrosarcoma protuberans. Plast Reconstr Surg 2007;119:1779–84.
  • Fiore M, Miceli R, Mussi C, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol 2005;23:7669–75.
  • Behbahani R, Patenotre P, Capon N, et al. [To a margin reduction in the dermatofibrosarcoma protuberans? Retrospective study of 34 cases]. Ann Chir Plast Esthet 2005;50:179–85. discussion 86– 8.
  • DuBay D, Cimmino V, Lowe L, et al. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer 2004;100:1008–16.
  • Chang CK, Jacobs IA, Salti GI. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 2004;30:341–5.
  • Stojadinovic A, Karpoff HM, Antonescu CR, et al. Dermatofibrosarcoma protuberans of the head and neck. Ann Surg Oncol 2000;7:696–704.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.